User:Mr. Ibrahem/Phenoxybenzamine

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Phenoxybenzamine
Clinical data
Trade namesDibenzyline
AHFS/Drugs.comMonograph
MedlinePlusa682059
Pregnancy
category
  • AU: B2
Routes of
administration
By mouth
Drug classAlpha blocker[1]
Pharmacokinetic data
Elimination half-life24 hours
Identifiers
  • (RS)-N-Benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine
Chemical and physical data
FormulaC18H22ClNO
Molar mass303.83 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • ClCCN(C(COc1ccccc1)C)Cc2ccccc2
  • InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3 checkY
  • Key:QZVCTJOXCFMACW-UHFFFAOYSA-N checkY
  (verify)

Phenoxybenzamine, sold under the brand name Dibenzyline among others, is a medication used to manage pheochromocytoma, peripheral vascular disease, and urinary retention.[1] It is taken by mouth.[1] Effects begin in hours and can last for a week.[1]

Common side effects include a stuffy nose, small pupils, and low blood pressure with standing.[1] Other side effects may include heart problems as a result of a faster heart rate.[1] It should not be used in people with porphyrias.[2] It is an alpha blocker.[1]

Phenoxybenzamine was approved for medical use in the United States in 1953.[1] It is available as a generic medication.[3] In the United States 60 tablets of 10 mg costs about 1,800 USD as of 2021.[3] In the United Kingdom this amount costs the NHS about £240.[2]

References[edit]

  1. ^ a b c d e f g h i j "Phenoxybenzamine Monograph for Professionals". Drugs.com. Archived from the original on 13 August 2021. Retrieved 28 October 2021.
  2. ^ a b BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 195. ISBN 978-0857114105.
  3. ^ a b "Phenoxybenzamine Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 31 October 2016. Retrieved 28 October 2021.